Clinical Trial Update: Raynaud's Treatment Study (RTS) [Phase 3]

View source ↗

Summary

Phase 3 Raynaud's Treatment Study (RTS) sponsored by the National Heart, Lung, and Blood Institute has completed; the trial focused on Raynaud's disease within …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Raynaud Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Phase 3 | Status: COMPLETED